| Name | Title | Contact Details |
|---|---|---|
Dennis Jakubowicz |
Vice President of Sales | Profile |
Sheri Bennett |
National Sales Director | Profile |
Andrea Lebrun |
Chief Financial Officer, Cs | Profile |
ANX Home Healthcare provides physician-ordered skilled nursing and health care services to homebound patients recovering from illness or injury. We have worked with physicians and families in developing custom home care solutions for patients requiring specialists in: • Wound care • Diabetes management • Cardiac rehabilitation • Physical therapy • Occupational therapy • Speech therapy • Nutritional assessments • Dietary counseling Our services are provided by a highly skilled interdisciplinary team of experts with over 75 years of combined experience in the health care industry. We pride ourselves in our ability to quickly respond to physician and clinician requests for patient home care. Best of all, you can count on us to provide service 24/7. With a team of full-time clinicians, we are able to initiate start of care within 24 hours. Established by Thomas Allandale Rocas III (RN, BSN, Certified Wound Care Specialist) and Lisa Mangubat (RN, BSN) in August 2007 with a vision of client-focused quality care and service for home-bound patients, ANX Home Healthcare is now in our ninth year of practice in the San Francisco Bay Area. We remain committed to providing competent and reliable care utilizing cutting-edge technology.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Quality Assurance Management is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Carrollton, TX. To find more information about Quality Assurance Management, please visit www.qam.com
Marino & Company is a Allendale, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Terumo Medical Corp is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.